 | |
| Company type | Subsidiary |
|---|---|
| Industry | Pharmaceuticals |
| Predecessor | J.F. Macfarlan Duncan Flockhart T&H Smith |
| Founded | 1815 |
| Defunct | June 2022 |
| Fate | Acquired by Altaris Capital Partners |
| Successor | Veranova |
| Headquarters | , Scotland, UK |
Area served | Global |
| Products | Opiate alkaloids, Bitrex |
| Owner | Johnson Matthey[1][2] |
| Website | veranova |
MacFarlan Smith is a pharmaceutical manufacturing company based in Edinburgh, Scotland, founded in 1815. After its sale from Johnson Matthey in June 2022 to Altaris Capital Partners,[3] Macfarlan Smith rebranded as Veranova.[4] Veranova is a CDMO specialising in the development and manufacturing of specialist and complex active pharmaceutical ingredients, or APIs. It has facilities across Europe and North America.
- ^ Cite error: The named reference
PIHistwas invoked but never defined (see the help page). - ^ Cite error: The named reference
MacSmithHistwas invoked but never defined (see the help page). - ^ "Johnson Matthey announces sale of Health | Veranova". veranova.com. 6 April 2022. Retrieved 11 May 2023.
- ^ "Johnson Matthey Health Rebrands as Veranova". PharmTech. Retrieved 11 May 2023.